Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

TL1A selectively enhances IL-12/IL-18-induced NK cell cytotoxicity against NK-resistant tumor targets.

Heidemann SC, Chavez V, Landers CJ, Kucharzik T, Prehn JL, Targan SR.

J Clin Immunol. 2010 Jul;30(4):531-8. doi: 10.1007/s10875-010-9382-9. Epub 2010 Mar 27.

PMID:
20349123
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells.

Papadakis KA, Prehn JL, Landers C, Han Q, Luo X, Cha SC, Wei P, Targan SR.

J Immunol. 2004 Jun 1;172(11):7002-7.

PMID:
15153521
[PubMed - indexed for MEDLINE]
Free Article
3.

Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.

Papadakis KA, Zhu D, Prehn JL, Landers C, Avanesyan A, Lafkas G, Targan SR.

J Immunol. 2005 Apr 15;174(8):4985-90.

PMID:
15814728
[PubMed - indexed for MEDLINE]
Free Article
4.

TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.

Meylan F, Richard AC, Siegel RM.

Immunol Rev. 2011 Nov;244(1):188-96. doi: 10.1111/j.1600-065X.2011.01068.x. Review.

PMID:
22017439
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Functional signaling of membrane-bound TL1A induces IFN-gamma expression.

Biener-Ramanujan E, Gonsky R, Ko B, Targan SR.

FEBS Lett. 2010 Jun 3;584(11):2376-80. doi: 10.1016/j.febslet.2010.04.030. Epub 2010 Apr 18.

PMID:
20403353
[PubMed - indexed for MEDLINE]
Free Article
6.

Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.

Bamias G, Mishina M, Nyce M, Ross WG, Kollias G, Rivera-Nieves J, Pizarro TT, Cominelli F.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8441-6. Epub 2006 May 12.

PMID:
16698931
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.

Ami K, Ohkawa T, Koike Y, Sato K, Habu Y, Iwai T, Seki S, Hiraide H.

Clin Exp Immunol. 2002 Jun;128(3):453-9.

PMID:
12109440
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.

Luedke E, Jaime-Ramirez AC, Bhave N, Roda J, Choudhary MM, Kumar B, Teknos TN, Carson WE 3rd.

Surgery. 2012 Sep;152(3):431-40. doi: 10.1016/j.surg.2012.05.035. Epub 2012 Jul 6.

PMID:
22770960
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.

Prehn JL, Mehdizadeh S, Landers CJ, Luo X, Cha SC, Wei P, Targan SR.

Clin Immunol. 2004 Jul;112(1):66-77.

PMID:
15207783
[PubMed - indexed for MEDLINE]
10.

Activation of porcine natural killer cells and lysis of foot-and-mouth disease virus infected cells.

Toka FN, Nfon CK, Dawson H, Estes DM, Golde WT.

J Interferon Cytokine Res. 2009 Mar;29(3):179-92. doi: 10.1089/jir.2008.0058.

PMID:
19196070
[PubMed - indexed for MEDLINE]
11.

Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.

Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.

J Immunol. 2001 Feb 1;166(3):1590-600.

PMID:
11160200
[PubMed - indexed for MEDLINE]
Free Article
12.

VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.

Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.

Exp Hematol. 1995 Dec;23(14):1530-4.

PMID:
8542943
[PubMed - indexed for MEDLINE]
13.

Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.

Park MH, Song MJ, Cho MC, Moon DC, Yoon do Y, Han SB, Hong JT.

Immunology. 2012 Jan;135(1):63-72. doi: 10.1111/j.1365-2567.2011.03513.x.

PMID:
22043900
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia.

Taraban VY, Slebioda TJ, Willoughby JE, Buchan SL, James S, Sheth B, Smyth NR, Thomas GJ, Wang EC, Al-Shamkhani A.

Mucosal Immunol. 2011 Mar;4(2):186-96. doi: 10.1038/mi.2010.70. Epub 2010 Oct 20.

PMID:
20962771
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells.

Lehmann C, Zeis M, Uharek L.

Br J Haematol. 2001 Sep;114(3):660-5.

PMID:
11552995
[PubMed - indexed for MEDLINE]
16.

Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.

Girart MV, Fuertes MB, Domaica CI, Rossi LE, Zwirner NW.

J Immunol. 2007 Sep 15;179(6):3472-9.

PMID:
17804388
[PubMed - indexed for MEDLINE]
Free Article
17.

TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.

Takedatsu H, Michelsen KS, Wei B, Landers CJ, Thomas LS, Dhall D, Braun J, Targan SR.

Gastroenterology. 2008 Aug;135(2):552-67. doi: 10.1053/j.gastro.2008.04.037. Epub 2008 May 7.

PMID:
18598698
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.

Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.

Hum Immunol. 2008 Aug;69(8):490-500. doi: 10.1016/j.humimm.2008.06.004. Epub 2008 Jul 9.

PMID:
18619507
[PubMed - indexed for MEDLINE]
19.

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.

Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G.

Eur J Immunol. 1993 Aug;23(8):1826-30.

PMID:
8102101
[PubMed - indexed for MEDLINE]
20.

Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.

Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.

Cancer Res. 2000 Sep 1;60(17):4838-44.

PMID:
10987295
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk